Latest Roswell Park Cancer Institute Stories
The National Comprehensive Cancer Network (NCCN) is developing a methodology for the evaluation and application of the Comparative Effectiveness of health care technologies in cancer care.
A drug developed with Pentagon approval offers protection from radiation in the event of a nuclear attack, U.S.
Improved communication among patients and primary care physicians increases the chances those due for colorectal cancer screening will follow their doctors' advice and complete the procedure, a University at Buffalo study has found.
NCCN announces open registration for a west coast session of NCCN Academy for Excellence & Leadership in Oncology(TM) School of Pharmaceutical & Biotech Business scheduled for July 9 - 10, 2009 in San Francisco.
A pilot study of a new productivity tool developed by the National Comprehensive Cancer Network (NCCN) shows potential in measuring the impact of mid-level oncology providers in outpatient oncology settings.
BUFFALO, N.Y., May 22 /PRNewswire-USNewswire/ -- Researchers at Roswell Park Cancer Institute (RPCI) in Buffalo, New York, are strongly advocating a national discussion about the need to vaccinate both young men and women against HPV 16 to prevent head & neck cancers.
NCCN recently updated the NCCN Guidelines for Venous Thromboembolic Disease, which includes both deep venous thrombosis (DVT) and pulmonary embolism (PE), and is a common condition in people with cancer.
NCCN recently updated the NCCN Guidelines for Central Nervous System (CNS) Cancers.
Preclinical Study is Subject of Upcoming ASCO Presentation BELLEVUE, Wash., May 18 /PRNewswire/ -- Light Sciences Oncology, Inc.
ATLANTA and BUFFALO, N.Y., May 7 /PRNewswire/ -- Roswell Park Cancer Institute (RPCI) is the first center in New York state to install Elekta's Leksell Gamma Knife(R) Perfexion(TM), an advanced radiosurgery device specifically designed to treat one or more lesions in the head in a single session.